DAFNA Capital Management LLC
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1389933
LOS ANGELES, CA
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,382,802
-$379,550 QoQ
Shares Held
267,402
-25.1% QoQ
Ownership
0.502%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#44
of 182 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DAFNA Capital Management LLC holds $266,800,868 across 59 Biotechnology names. KALV ranks #13 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
580,678 | $56,470,935 | |
| 2 | DAWN |
Day One Biopharmaceuticals, Inc.
|
978,463 | $20,978,246 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
476,740 | $15,884,976 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $14,582,391 | |
| 5 | CYTK |
Cytokinetics Inc
|
217,497 | $14,335,227 | |
| 6 | NKTR |
Nektar Therapeutics
|
165,178 | $11,884,557 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
443,829 | $9,586,706 | |
| 8 | LRMR |
Larimar Therapeutics, Inc.
|
2,029,164 | $9,131,238 |
All Filings in KALV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,382,802 | 267,402 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,762,352 | 356,802 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,148,863 | 422,731 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,576,762 | 581,757 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,682,222 | 752,359 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,874,912 | 811,678 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,380,191 | 723,678 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,506,141 | 806,973 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,570,699 | 806,973 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,362,642 | 601,032 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,831,273 | 605,532 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,499,288 | 611,032 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,842,011 | 616,032 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,164,376 | 616,032 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,704,591 | 255,313 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,614,123 | 265,663 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,810,372 | 190,663 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,522,471 | 190,663 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,300,894 | 189,163 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,451,976 | 60,600 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,505,434 | 58,600 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $2,619,399 | 208,054 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,691,669 | 222,452 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,797,382 | 234,952 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||